Assenagon Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-769,336
| Closed | -$4.49M | – | 1491 |
|
|
2022
Q4 | $4.49M | Sell |
769,336
-140,554
| -15% | -$821K | 0.02% | 528 |
|
|
2022
Q3 | $6.1M | Buy |
909,890
+361,047
| +66% | +$2.42M | 0.02% | 421 |
|
|
2022
Q2 | $2.31M | Buy |
548,843
+516,912
| +1,619% | +$2.18M | 0.01% | 763 |
|
|
2022
Q1 | $108K | Sell |
31,931
-110,033
| -78% | -$372K | ﹤0.01% | 1329 |
|
|
2021
Q4 | $447K | Sell |
141,964
-94,403
| -40% | -$297K | ﹤0.01% | 1170 |
|
|
2021
Q3 | $773K | Buy |
236,367
+94,681
| +67% | +$310K | ﹤0.01% | 929 |
|
|
2021
Q2 | $598K | Buy |
141,686
+15,654
| +12% | +$66.1K | ﹤0.01% | 974 |
|
|
2021
Q1 | $629K | Buy |
+126,032
| New | +$629K | ﹤0.01% | 962 |
|
|
2019
Q3 | – | Sell |
-109,588
| Closed | -$1.32M | – | 1090 |
|
|
2019
Q2 | $1.32M | Buy |
+109,588
| New | +$1.32M | 0.01% | 610 |
|